- Home
- ORIC vs ABSI Comparison
ORIC vs ABSI Comparison
Compare ORIC & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- ABSI
- Stock Information
- Founded
- ORIC 2014
- ABSI 2011
- Country
- ORIC United States
- ABSI United States
- Employees
- ORIC N/A
- ABSI N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- ORIC Health Care
- ABSI Health Care
- Exchange
- ORIC Nasdaq
- ABSI Nasdaq
- Market Cap
- ORIC 362.9M
- ABSI 338.0M
- IPO Year
- ORIC 2020
- ABSI 2021
- Fundamental
- Price
- ORIC $11.10
- ABSI $2.67
- Analyst Decision
- ORIC Strong Buy
- ABSI Strong Buy
- Analyst Count
- ORIC 9
- ABSI 4
- Target Price
- ORIC $18.29
- ABSI $8.75
- AVG Volume (30 Days)
- ORIC 949.2K
- ABSI 4.1M
- Earning Date
- ORIC 08-11-2025
- ABSI 08-13-2025
- Dividend Yield
- ORIC N/A
- ABSI N/A
- EPS Growth
- ORIC N/A
- ABSI N/A
- EPS
- ORIC N/A
- ABSI N/A
- Revenue
- ORIC N/A
- ABSI $4,815,000.00
- Revenue This Year
- ORIC N/A
- ABSI $81.76
- Revenue Next Year
- ORIC N/A
- ABSI $287.79
- P/E Ratio
- ORIC N/A
- ABSI N/A
- Revenue Growth
- ORIC N/A
- ABSI N/A
- 52 Week Low
- ORIC $3.90
- ABSI $2.01
- 52 Week High
- ORIC $14.67
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- ORIC 66.82
- ABSI 46.51
- Support Level
- ORIC $10.42
- ABSI $2.54
- Resistance Level
- ORIC $11.50
- ABSI $2.92
- Average True Range (ATR)
- ORIC 0.62
- ABSI 0.15
- MACD
- ORIC -0.03
- ABSI 0.01
- Stochastic Oscillator
- ORIC 83.30
- ABSI 41.86
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.